Dr. Manfred Werner Raiser, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3825 Highland Ave, Suite 203, Downers Grove, IL 60515 Phone: 630-969-1167 Fax: 630-969-1297 |
Dr. Rockford Glenn Yapp, M.D., M.P.H. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3825 Highland Ave, Tower 2 - Suite 302, Downers Grove, IL 60515 Phone: 630-434-9312 Fax: 630-434-9360 |
Dr. John L Holden, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 3825 Highland Ave Suite 203, Downers Grove, IL 60515 Phone: 630-969-1167 Fax: 630-969-1284 |
Dr. James Ralph Clark, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3825 Highland Ave, Tower 2 - Suite 302, Downers Grove, IL 60515 Phone: 630-434-9312 Fax: 630-434-9360 |
Dr. Anshuman Chawla, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3825 Highland Ave, Tower 2 - Suite 302, Downers Grove, IL 60515 Phone: 630-434-9312 Fax: 630-434-9360 |
Dr. David Philip Gerard, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3825 Highland Ave, Suite 203, Downers Grove, IL 60515 Phone: 630-969-1167 Fax: 630-969-1297 |
News Archive
The American Academy of Pediatrics (AAP) is recommending in a new report that children with lactose intolerance should include dairy foods as part of a healthy diet in order to get enough calcium, vitamin D, protein and other nutrients essential for bone health and overall growth.
The hard cider industry is experiencing remarkable growth; statistics show that US hard cider production increased 22-fold from 2007-2015.
Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.
Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.
› Verified 8 days ago